Coronavirus: chief executive says testing BioNTech-Pfizer vaccine on new Covid-19 variant

• Ugur Sahin said the shot should be able to cope with a strain first detected in Britain that appears to be more contagious
• He also said BioNTech’s new plant in Germany may be operational in February and produce 250 million doses in the first half of the year